Avalon GloboCare Corp.

Avalon GloboCare maintains a capital structure characterized by zero debt-to-equity but severe liquidity constraints, with a current ratio of 0.38 indicating that current liabilities significantly exceed current assets. The company holds $775,995 in cash and equivalents against total assets of $16.2 million and total liabilities of $4.5 million. The valuation snapshot reflects a market cap of $3.19 million and a negative EV/EBITDA of -0.89, underscoring the speculative nature of the equity. The diluted share count of 8.96 million exceeds the basic count of 8.32 million, signaling active dilution mechanisms.

Profitability remains deeply negative, with a net income loss of $4.48 million and an operating income loss of $2.72 million for the period. Return on equity stands at -38.21% and return on assets at -27.58%, reflecting the erosion of shareholder value due to sustained operational losses. The company lacks positive cash flow from operations, relying instead on financing activities to sustain liquidity.

Revenue exposure is split between emerging segments: the KetoAir device, distributed via Q&A Distribution LLC, and the RPM automated video production platform, developed by Avalon Quantum AI. The KetoAir device is in an early-stage commercial testing phase, while the RPM platform targets the creator economy with AI-powered content generation. No specific revenue mix percentages are disclosed, but the strategic focus is shifting toward these two primary product lines.

Growth trajectory is obscured by the lack of historical revenue data in the provided snapshot, but cash flow statements reveal a net loss from continuing operations of $4.38 million in Q1 2026, compared to $2.27 million in the prior year period. The company generated $3.25 million in proceeds from a February 2026 private offering, which was critical in offsetting the $2.86 million net cash used in operating activities. This reliance on external capital highlights the absence of organic growth funding.

Risk factors are elevated, with high liquidity and dilution risks flagged. Filings reference going-concern or substantial-doubt language, and the current ratio of 0.38 confirms an inability to meet short-term obligations without further capital raises. The diluted share count being moderately above the basic count, combined with recent debt issuances and convertible notes, points to ongoing pressure on existing shareholders.

Recent events include an 8-K filing with high-severity items related to material agreements and equity changes. The company also reported non-cash investing and financing activities, including the conversion of convertible notes and preferred stock into common stock, further contributing to share count expansion. The February 2026 private offering provided a temporary liquidity buffer, but the underlying operational losses persist.

Operating income -$2.7M.

• ▍Operating income -$2.7M

Revenue $1.1M; Operating income -$5.8M.

• ▍Revenue $1.1M
• ▍Operating income -$5.8M
• ▍Net margin -1541.9%

Revenue $700.2k; Operating income -$5.7M.

• ▍Revenue $700.2k
• ▍Operating income -$5.7M
• ▍Net margin -2276.6%

Operating income -$7.6M.

• ▍Operating income -$7.6M

Revenue $0.00.

• ▍Revenue $0.00

Revenue $1.3M; Operating income -$4.9M.

• ▍Revenue $1.3M
• ▍Operating income -$4.9M
• ▍Net margin -592.7%

Operating income -$4.8M.

• ▍Operating income -$4.8M